- SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
-
Syahniar R, Kharisma DS
- KMID: 2534988
- Clin Exp Vaccine Res.
- 2022 May;11(2):173-183.
- doi: 10.7774/cevr.2022.11.2.173
The coronavirus disease 2019 pandemic has not ended, and several variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continue to emerge. The emergence of new variants is... -
- CITED
-
- Close
- SHARE
-
- Close
